Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Persons > All

Find below all kinds of persons from France & Monaco.

Total search results: 1633 | Ordered by Person (ascending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingRegion
Toyne-Sewell, Melanie (Instinctif Partners 201509) Public Relations Manager / Investor Relations Manager Instinctif Partners (Group) Greater London (region)
Tramoy, Philippe (Seventure Partners 201504 Investment Director at Quadrivium 1 seed fund) Chief Executive Officer (CEO) BPCE (Group) Île-de-France (region)
Tregoning, Kathleen (Sanofi 201702– EVP External Affairs before Biogen) Public Relations Manager / Investor Relations Manager Sanofi (Group) [since May 2011] Île-de-France (region)
Treillou, Jean-Luc (LNC Therapeutics 201807– Chairman before CEO) Board member, non-executive LNC Therapeutics (FR) Aquitaine (region)
Trépo, Nathalie (Onxeo 20511– Investor Relations before Neovacs + Theradiag) Public Relations Manager / Investor Relations Manager Onxeo (Group) Île-de-France (region)
Tripodi, Federico A. (Cellectis 201609c– CEO of Calyxt before Monsanto) Chief Executive Officer (CEO) Cellectis (Group) Minnesota (federal state)
Triva, Stefania (Copan 201501 CEO + General Manager) Chief Executive Officer (CEO) Copan (Group) Lombardia (Lombardy)
Trombe, Emmanuelle (McDermott Will & Emery 201701 Partner in Life Sciences Group in Paris) Attorney / Lawyer McDermott Will & Emery (MWE) (Group) Île-de-France (region)
Tupin, Cyrille (Cerenis Therapeutics 201702 CFO) Chief Financial Officer (CFO) Cerenis (Group) Midi-Pyrénées (region)
Tupinon-Mathieu, Isabelle (Servier 201411 Head of Metabolism Innovative Center) Research & Development Manager Servier (Group) Île-de-France (region)
Turenne, G. Andre (Voyager Therapeutics 201807– CEO before Sanofi + Genzyme + Feinstein Kean Healthcare) Chief Executive Officer (CEO) Voyager Therapeutics Inc. (Nasdaq: VYGR) Massachusetts (federal state)
Turner, Stephen (Steve) (Protea Biosciences 201002 CEO) Chief Executive Officer (CEO) Protea Biosciences (Group) West Virginia (federal state)
Ubags, Frank (Cevec 201504– CEO before COO since 201409 before Coral BioNet + Scil Proteins + Kiadis + Rhein Biotech) Chief Operating Officer (COO) Cevec (Group) Nordrhein-Westfalen (federal state)
Ulrich, Peter G. (TargeGen 201006 CEO + Co-founder) Chief Executive Officer (CEO) Sanofi (Group) [since May 2011] California (federal state)
Unkelbach, Gerd (Fraunhofer 201311 Head of CBP in Leuna) n. a. Fraunhofer (Group) Sachsen (federal state)
Unterrainer, Gertraud (ProBioGen 200710– CFO before Biovertis) Chief Financial Officer (CFO) Minapharm (Group) Berlin (federal state)
Vadsholt, Anders (TopoTarget 201011 CFO) Chief Financial Officer (CFO) Onxeo (Group) Hovedstaden
Vaeck, Mark (Complix 201005– CEO before co-founder + founding CEO of ActoGenix + before Ablynx CEO) Chief Executive Officer (CEO) Complix (Group) Flanders (Flemish region)
Vaillant, Renaud (Theravectys 201209 CEO + France Biotech 201508 Board Director) Chief Executive Officer (CEO) Theravectys S.A. Île-de-France (region)
Valachs, Philippe (Cellectis 201110– General Secretary) management (personnel) Cellectis (Group) Île-de-France (region)
Valencony, Francois (Mérieux 201601 General Manager of Mérieux Developpement) General Manager (management) Mérieux (Group) Rhône-Alpes (region)
Valla, Sophie (Keranova 201604 before Bausch and Lomb / Valeant) n. a. Keranova (FR) France (region/state unspecified)
Valle, Francois (Vaxon Biotech 201412 CEO + MabLife 2014 CEO before Genewave) Chief Executive Officer (CEO) Vaxon Biotech S.A. Île-de-France (region)
Van Beneden, Patrick (GIMV 201306) Investment Manager Gimv (Group) Belgium_o
Van Broekhoven, Annie (Q-Biologicals 201211 CEO) Chief Executive Officer (CEO) Eurofins (Group) Flanders (Flemish region)
van de Stolpe, Onno (Galapagos 200501 CEO) Chief Executive Officer (CEO) Galapagos (Group) Flanders (Flemish region)
Van der Geyten, Serge (JnJ 201501 Director for Neuroscience External Affairs at Janssen Pharmaceutica NV) Business Development Manager / Strategy Manager Johnson & Johnson (JnJ) (Group) Belgium_o
van Eikeren, Paul (Blue Reference 200805 CEO) Chief Executive Officer (CEO) Waters (Group) Oregon (federal state)
van Gaver, Géraud (Mérieux 201304 Head of Corp Market Resarch + Bus Intelligence at bioMérieux before BMS + BD) market research Mérieux (Group) Rhône-Alpes (region)
van Gorp, Ad (Lead Pharma 201502 CEO + Co-founder) Chief Executive Officer (CEO) Lead Pharma Holding B.V. Gelderland (province)
van Mierle, Mark (Reed Elsevier 201301 Managing Director Elsevier Pharmaceutical + Biotech Group) Managing Director Reed Elsevier (Group) North Holland (province, NL)
Van Nieuwenhove, Thierry (Novasep 201401– President of Synthesis Business Unit) President/Director/Head Business Group/Unit/Division Novasep (Group) Lorraine (region)
van Tetering, Rob (Florimond Desprez 201404 CEO of SESVanderHave) Chief Executive Officer (CEO) Florimond Desprez (Group) Belgium_o
van Tunen, Arjen (Keygene 200601 CEO) Chief Executive Officer (CEO) KeyGene N.V. Gelderland (province)
van Weperen, Willem W. (Prosensa 201406– CCO before to-BBB 200902–201406 CEO before Genzyme Netherlands) Chief Commercial Officer (CCO) BioMarin (Group) South Holland (province, NL)
Vanhove, Bernard (OSE Immunotherapeutics 201707 COO) Chief Operating Officer (COO) OSE Immunotherapeutics (Group) Pays de la Loire (region)
Vassiliou, Androula (EU 200802– Health Commissioner) Administrative Officer (personnel) EU (govt) Brussels (region)
Vaussy, Hugues (Eurofins 201707 Finance Director) Chief Financial Officer (CFO) Eurofins (Group) Luxembourg (cl=4)
Vega, Manuel (Aurgalys 2010– Partner before Nautilus Biotech 1999–2007 CEO + Founder before Genethon) n. a. Aurgalys S.A.S. Île-de-France (region)
Veillet, Stanislas (Biophytis 200609– CEO + Co-founder) Chief Executive Officer (CEO) Biophytis (Group) Île-de-France (region)
Verleysen, Katleen (Pronota 201201– CEO before COO) Chief Executive Officer (CEO) MyCartis Flanders (Flemish region)
Vermersch, Matthieu (New Protein Capital 201412 Director + Founder) President/Director/Head Business Group/Unit/Division New Protein Capital (NPC) (SG) Singapore (cl=4)
Vervaecke, Etienne (Lille-Eurosanté 201706 General Manager) Cluster Manager GIE Eurasanté Nord-Pas-de-Calais (region)
Vezina, Louis-Philippe (Medicago 201201 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Medicago Inc. Québec
Vial, Daniel (Consultant before IMS Health + France Biotech 201508 Board Member) consulting (economic) Sanofi (Group) [since May 2011] Île-de-France (region)
Vidal, Véronique (Imaxio 201207 Head of Genomics division) President/Director/Head Business Group/Unit/Division Imaxio (Group) Rhône-Alpes (region)
Viehbacher, Christopher A. (Chris) (Bertarelli Group 201510 Managin Partner Gurnet Point Capital before Sanofi + GSK) Managing Partner BERTARELLI Group (family of Ernesto Bertarelli) Channel Islands (Non-Commonwealth / Non-EU tax haven)
Viens, Patrice (Unicancer 201507 CEO of Institut Paloi-Calmettes) Chief Executive Officer (CEO) Unicancer (Group) Provence-Alpes-Côte d’Azur (region)
Villain-Guillot, Philippe (Nosopharm 201703 President) Chief Executive Officer (CEO) Nosopharm S.A.S. Rhône-Alpes (region)
Villalgordo, José Manuel (Villapharma Research 201612 CEO) Chief Executive Officer (CEO) Eurofins (Group) Spain_o
Villecroze, Stéphane (Demeter Partners 201412 Managing Director) Managing Director Demeter (Group) Île-de-France (region)
Villette, Astrid (FTI Consulting 201612 FTI Consulting Paris) Public Relations Manager / Investor Relations Manager FTI Consulting (Group) Île-de-France (region)
Vitt, Daniel (Immunic 201701– CEO before 4SC 1997–201612 CSO + Co-Founder before Univ Würzburg) Chief Executive Officer (CEO) Immunic AG Bayern (federal state)
Vogel, Hanspeter (Bruker 201009 Director RI Research Instruments GmbH) n. a. Bruker Corporation (Group) Germany (state/region unspecified)
Vogt, Reinhard (Sartorius 201308 Executive Board Member, Marketing, Sales, Services) Sales Manager / Marketing Manager Sartorius (Group) Niedersachsen (federal state)
Voisin, Céline (ATCG Partners 201705 Director + Co-Founder) Public Relations Manager / Investor Relations Manager ATCG Partners (FR) Provence-Alpes-Côte d’Azur (region)
Voisin, Emmanuelle M. (Voisin Consulting 1997– CEO + Founder) Company Founder Voisin Consulting Life Sciences (VCLS) Île-de-France (region)
Volatier, Jean (Inventiva 2017 Chief Administrative + Financial Officer) Chief Financial Officer (CFO) Inventiva S.A. (Euronext Paris: IVA) Bourgogne (region)
von Braunmühl, Benedikt (Qiagen 201301– promoted SVP Commercial Operations at Qiagen since 2008) President/Director/Head Business Group/Unit/Division Qiagen (Group) Nordrhein-Westfalen (federal state)
von Gabain, Alexander (Intercell 200311) n. a. Valneva (Group) Wien (state)
Vonderscher, Jacky (Enyo Pharma 201602 CEO) Chief Executive Officer (CEO) Enyo Pharma S.A. Rhône-Alpes (region)
Vuillermet, Axelle (NewCap. 201203 Public Relations Manager) Public Relations Manager / Investor Relations Manager NewCap. – Investor Relations & Financial Communications Île-de-France (region)
Waanders, Gary (Bryan Garnier 201709– Managing Director at European Healthcare division before Zeus Capital + Nomura) Managing Director Bryan, Garnier & Co., Ltd. Greater London (region)
Wacker, Ron (SGS 201106– Global BusDev Manager Food Testing before Danone + Chimera Biotec) Business Development Manager / Strategy Manager SGS (Group) Région Lémanique (region)
Wagner, Julian (Pevion Biotech 201110 Business Development) Business Development Manager / Strategy Manager Pevion Biotech AG Espace Mittelland (region)
Wagtmann, Nicolai (Innate Pharma 201507 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Innate Pharma S.A. (Euronext Paris: IPH) Provence-Alpes-Côte d’Azur (region)
Wahr, Christine M. (McDermott Will & Emery 201709 Associate in Boston) Attorney / Lawyer McDermott Will & Emery (MWE) (Group) Île-de-France (region)
Wakefield, James (Novacyt 201704 Board Chairman) Board member, non-executive Novacyt (Group) Île-de-France (region)
Walker, Jerry (Lab21 –200710– CEO) Chief Executive Officer (CEO) Novacyt (Group) South East England (region)
Waller, Ivana (Accovion 201010 COO) Chief Operating Officer (COO) Clinipace (Group) Hessen (federal state)
Walls, Matthew (EpiStem 200704 CEO) Chief Executive Officer (CEO) Epistem (Group) North West England (region)
Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal) Chief Executive Officer (CEO) GlaxoSmithKline (GSK) (Group) United Kingdom (state/region unspecified)
Walrafen, Pierre (Scipio Bioscience 201711 CEO) Chief Executive Officer (CEO) Scipio Bioscience S.A.S. Île-de-France (region)
Walter, Monika (Hyglos 2010 Manager Operations) Chief Operating Officer (COO) Mérieux (Group) Bayern (federal state)
Wang, Haixang (APG Bio (CN) 201706 CEO) Sales Manager / Marketing Manager Shanghai (province)
Ward, Nagib (Deinove 201307– VP Business Development before Novozymes North America Inc) Business Development Manager / Strategy Manager Deinove S.A. (Euronext Growth: ALDEI.PA) Île-de-France (region)
Watt, Alan (NodThera Ltd 201806 CSO + acting CEO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) NodThera Ltd. East of England (region)
Wattin, Martin (Contur Software AB 201105 CEO) Chief Executive Officer (CEO) Dassault Systèmes (3DS) (Group) Stockholm (region)
Waymel, Bertrand (Novasep 201505– promoted to Group Human Resources Director joined Novasep in 2012) Human Resources Manager Novasep (Group) Lorraine (region)
Weber, Matthias-Wilbur (Eurofins 200701–201412 CFO died 12/14) Chief Financial Officer (CFO) Eurofins (Group) Pays de la Loire (region)
Weinand, Dieter (Sanofi 201811– Head Primary Care Unit before Bayer + Otsuka + Pfzer + BMS) President/Director/Head Business Group/Unit/Division Sanofi (Group) [since May 2011]
Weir, Neil (Sitryx Therapeutics 201804– CEO before UCB SVP Discovery) Chief Executive Officer (CEO) Sitryx Therapeutics Ltd. South East England (region)
Weiss, Mario (GAIA 201702 CEO + Founder) Chief Executive Officer (CEO) GAIA AG Hamburg (federal state)
Welch, William J. (Bill) (Sequenom 201101– SVP Diagnostics before Monogram 200803– before Dade Behring before La Jolla) Sales Manager / Marketing Manager LabCorp (Group) California (federal state)
Welsh, Chris (Consilium Strategic Communications 201707) Public Relations Manager / Investor Relations Manager Consilium Strategic Communications Ltd. (CSC) Greater London (region)
Werner, Thomas (Board Member of several companies before GSK SVP) Board member, non-executive GlaxoSmithKline (GSK) (Group) United Kingdom (state/region unspecified)
Weß, Ludger (akampion before 2001–2006 BioCentury Senior Editor before Financial Times Deutschland) Public Relations Manager / Investor Relations Manager Akampion Hamburg (federal state)
White, Janet (Lonza 201109 Head Development Services) President/Director/Head Business Group/Unit/Division Lonza Group (Group) Northwestern Switzerland (region)
Whittingham, Jerel (Myconostica 200804 CEO) Chief Executive Officer (CEO) Novacyt (Group) North West England (region)
Wicke, Ilka (Boehringer 201203 Director at Boehringer Ingelheim Venture Fund) Investment Manager Boehringer Ingelheim Venture Fund (BIVF) Rheinland-Pfalz (federal state)
Wicki, Andreas (HBM Healthcare Investments 201402 CEO) Chief Executive Officer (CEO) HBM (Group) Central Switzerland (region)
Wiedemann, Sonja (Eurofins 201801 Managing Director at Eurofins Genomics GmbH) Managing Director Eurofins (Group) Bayern (federal state)
Wilking, Karsten (Polyplus-transfection 2017– CEO before Life Technologies/Applied Bisystems/Invitrogen) Managing Director Polyplus-transfection (Group) Alsace (Elsass) (region)
WIlliams, Jeff (Clinipace 201504 CEO) Chief Executive Officer (CEO) Clinipace (Group) North Carolina (federal state)
Wilson, Dominic (Bryan Garnier 201709– Managing Director at European Healthcare division before Zeus Capital + Nomura) Managing Director Bryan, Garnier & Co., Ltd. Greater London (region)
Wilson, Ian (Edinburgh Molecular Imaging 201603 CEO) Chief Executive Officer (CEO) Edinburgh Molecular Imaging Ltd. (EM Imaging) Scotland
Windhab, Norbert n. a. Sanofi (Group) [since May 2011] Hessen (federal state)
Wisniewski, Raphaël (LCF Rothschild 200511 Edmond de Rothschild Investment Partners) Partner (venture partner) Andera Partners (FR) Île-de-France (region)
Witz, Pascale (Sanofi 201307–201605 EVP before GE Healthcare + Becton Dickinson LEFT 6/16) President/Director/Head Business Group/Unit/Division Sanofi (Group) [since May 2011] Île-de-France (region)
Woiwode, Tom (Versant Ventures 201404 before Synosis + Xenoport) Venture Partner Versant Ventures California (federal state)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top